NYLIM
CVS icon

New York Life Investment Management’s CVS Health CVS Stock Holding History

New York Life Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Buy
177,779
+1,164
+0.7% +$104K 0.13% 138
2026
Q1 		$12.7M Buy
176,615
+2,664
+2% +$205K 0.11% 163
2025
Q4 		$13.8M Buy
173,951
+1,911
+1% +$151K 0.12% 146
2025
Q3 		$13M Buy
172,040
+140
+0.1% +$9.6K 0.11% 166
2025
Q2 		$11.9M Buy
171,900
+3,412
+2% +$224K 0.11% 170
2025
Q1 		$11.4M Sell
168,488
-187
-0.1% -$11.2K 0.12% 160
2024
Q4 		$7.57M Buy
168,675
+1,370
+0.8% +$76.9K 0.07% 240
2024
Q3 		$10.5M Sell
167,305
-5,196
-3% -$303K 0.1% 187
2024
Q2 		$10.2M Buy
172,501
+493
+0.3% +$30.8K 0.1% 186
2024
Q1 		$13.7M Sell
172,008
-10,145
-6% -$775K 0.14% 143
2023
Q4 		$14.4M Sell
182,153
-49,167
-21% -$3.5M 0.15% 138
2023
Q3 		$16.2M Sell
231,320
-5,177
-2% -$367K 0.17% 114
2023
Q2 		$16.3M Buy
236,497
+17,951
+8% +$1.28M 0.17% 124
2023
Q1 		$16.2M Buy
218,546
+2,200
+1% +$184K 0.18% 124
2022
Q4 		$20.2M Sell
216,346
-341
-0.2% -$32.9K 0.23% 104
2022
Q3 		$20.7M Sell
216,687
-673
-0.3% -$66.6K 0.25% 78
2022
Q2 		$20.1M Buy
+217,360
New +$21.2M 0.23% 89

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

New York Life Investment Management's CVS Position: Q2 2026 in Review

New York Life Investment Management increased its CVS Health (CVS) stake by 0.66% in Q2 2026, buying an estimated $104K and bringing the position to 177,779 shares worth $18.4M. The position accounts for 0.13% of the portfolio, ranked #138.

New York Life Investment Management first reported a position in CVS in Q2 2022 and has held it in 17 quarters since. The position peaked at $20.7M in Q3 2022. 1,589 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • New York Life Investment Management held 177,779 shares of CVS Health worth $18.4M as of Q2 2026.
  • New York Life Investment Management bought 1,164 CVS Health shares in Q2 2026, an estimated $104K.
  • CVS Health made up 0.13% of New York Life Investment Management's portfolio in Q2 2026, its #138 holding.
  • New York Life Investment Management first reported a position in CVS Health in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's CVS Health position peaked at $20.7M in Q3 2022.
  • 1,589 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.